Q2 results were a total disaster. Only 1000 tests were sold in Q2 after almost 5000 sold in Q1.
On Page 28 of Q2 10-Q go to the bottom and read the last paragraph.
I really have not focused on the number of shares lately. Since production started I have only focused on revenue.
Last time AXIM management was this quiet they had apparently screwed up manufacturing and after 5 months of silence hired contract manufacturer Auer Precision at the end of December. Q1 sales were very promising. Then the announcement about the Parkinsons disease test. Then absolutely nothing. The Parkinsons disease test was barely mentioned in the Q2 10-Q.
I have no clue what AXIM management has screwed up this time.
Only 1000 tests sold in Q2.
Verséa Ophthalmics new customer announcements on LinkedIn have dropped from one every week to maybe one a month.
When AXIM management is this quiet, my guess is they screwed something up.